+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030- Product Image
Global Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030- Product Image
Sale

Global Paracetamol IV Market by Indication (Pain, Pyrexia/Fever), Application (Non-surgical, Surgical), End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666251
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Paracetamol IV Market size was estimated at USD 940.79 million in 2023, USD 1,008.13 million in 2024, and is expected to grow at a CAGR of 7.64% to reach USD 1,575.45 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paracetamol IV Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paracetamol IV Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Paracetamol IV Market, highlighting leading vendors and their innovative profiles. These include Aurobindo Pharma Ltd., Biological E. Limited, Cfl Pharmaceuticals Limited, Changshu Huagang Pharmaceuticals Co., Ltd., Dr. Reddy's Laboratories Ltd., Geno Pharmaceuticals Private Limited, Hebei Jiheng Pharmaceutical Co.,Ltd., Huzhou Konch Pharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Mallinckrodt PLC, Novartis AG, Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Zhejiang Kangle Pharmaceutical Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Paracetamol IV Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Pain
    • Pyrexia/Fever
  • Application
    • Non-surgical
    • Surgical
  • End-use
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Paracetamol IV Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Paracetamol IV Market?
  3. What are the technology trends and regulatory frameworks in the Paracetamol IV Market?
  4. What is the market share of the leading vendors in the Paracetamol IV Market?
  5. Which modes and strategic moves are suitable for entering the Paracetamol IV Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Paracetamol IV Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of indicative diseases and conditions
5.1.1.2. Increasing use of paracetamol IV in relieving fever in post-surgical procedures
5.1.1.3. Enhanced usage of acetaminophen to reduce the dependence on opioids for pain management
5.1.2. Restraints
5.1.2.1. Availability of multiple generic products
5.1.3. Opportunities
5.1.3.1. Government initiatives and rising research and development activities
5.1.3.2. Use of paracetamol IV in combination with non-steroidal anti-inflammatory drugs (NSAID) and narcotics
5.1.4. Challenges
5.1.4.1. Lack of experienced healthcare professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Paracetamol IV Market, by Indication
6.1. Introduction
6.2. Pain
6.3. Pyrexia/Fever
7. Paracetamol IV Market, by Application
7.1. Introduction
7.2. Non-surgical
7.3. Surgical
8. Paracetamol IV Market, by End-use
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Paracetamol IV Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Paracetamol IV Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Paracetamol IV Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aurobindo Pharma Ltd.
13.1.2. Biological E. Limited
13.1.3. Cfl Pharmaceuticals Limited
13.1.4. Changshu Huagang Pharmaceuticals Co., Ltd.
13.1.5. Dr. Reddy's Laboratories Ltd.
13.1.6. Geno Pharmaceuticals Private Limited
13.1.7. Hebei Jiheng Pharmaceutical Co.,Ltd.
13.1.8. Huzhou Konch Pharmaceutical Co., Ltd.
13.1.9. Lupin Pharmaceuticals, Inc.
13.1.10. Mallinckrodt PLC
13.1.11. Novartis AG
13.1.12. Sanofi S.A.
13.1.13. Sun Pharmaceutical Industries Limited
13.1.14. Teva Pharmaceutical Industries Ltd.
13.1.15. Zhejiang Kangle Pharmaceutical Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PARACETAMOL IV MARKET RESEARCH PROCESS
FIGURE 2. PARACETAMOL IV MARKET SIZE, 2023 VS 2030
FIGURE 3. PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PARACETAMOL IV MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PARACETAMOL IV MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PARACETAMOL IV MARKET DYNAMICS
FIGURE 7. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PARACETAMOL IV MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. PARACETAMOL IV MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PARACETAMOL IV MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PARACETAMOL IV MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PARACETAMOL IV MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PARACETAMOL IV MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. PARACETAMOL IV MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PARACETAMOL IV MARKET SIZE, BY PYREXIA/FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PARACETAMOL IV MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PARACETAMOL IV MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 12. PARACETAMOL IV MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PARACETAMOL IV MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. CANADA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. CANADA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. MEXICO PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. MEXICO PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PARACETAMOL IV MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. CHINA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. CHINA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. INDIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. INDIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. JAPAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. JAPAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. THAILAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. THAILAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PARACETAMOL IV MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. DENMARK PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. DENMARK PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EGYPT PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. EGYPT PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. FINLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. FINLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. GERMANY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. ITALY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. ITALY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. NORWAY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. NORWAY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. POLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. POLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. QATAR PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. QATAR PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. TURKEY PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. TURKEY PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM PARACETAMOL IV MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. PARACETAMOL IV MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 142. PARACETAMOL IV MARKET SHARE, BY KEY PLAYER, 2023
TABLE 143. PARACETAMOL IV MARKET LICENSE & PRICING

Companies Mentioned

  • Aurobindo Pharma Ltd.
  • Biological E. Limited
  • Cfl Pharmaceuticals Limited
  • Changshu Huagang Pharmaceuticals Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Geno Pharmaceuticals Private Limited
  • Hebei Jiheng Pharmaceutical Co.,Ltd.
  • Huzhou Konch Pharmaceutical Co., Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Mallinckrodt PLC
  • Novartis AG
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Zhejiang Kangle Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.57 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Paracetamol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Paracetamol Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 103 Pages
  • Global
From
Global Paracetamol Market Report and Forecast 2024-2032 - Product Image

Global Paracetamol Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Paracetamol (CAS 103-90-2) Global Market Research Report 2024 - Product Image

Paracetamol (CAS 103-90-2) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
2023 Global Forecast for Paracetamol Iv Market (2024-2029 Outlook) - High Tech & Emerging Markets Report - Product Image

2023 Global Forecast for Paracetamol Iv Market (2024-2029 Outlook) - High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nicotine Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From

About the Intravenous Paracetamol Market

Within the context of over-the-counter (OTC) drugs, intravenous paracetamol, also known as acetaminophen, occupies a specialized niche. While paracetamol in oral forms, such as tablets or liquids, is widely available without a prescription and well-used for treating pain and fever, its intravenous counterpart is typically used in clinical settings. Intravenous paracetamol is reserved for administering to patients who are unable to take oral medication, offering a rapid onset of pain relief or fever control. It is commonly utilized in hospitals for postoperative pain management or when precise dosage control is necessary. The distinction between the general OTC products and intravenous formulations is marked by the latter's requirement for medical supervision and administration. Some companies that produce or distribute intravenous paracetamol include Pfizer, which has a portfolio of pharmaceutical products that spans a variety of delivery methods, including intravenous solutions. Baxter International is another player in this market, providing medically essential products, including injectable drugs. Another notable company is Fresenius Kabi, a healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, which includes intravenous paracetamol in its lineup. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.